Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: manfredhasler who wrote (14554)	9/15/2000 9:36:21 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

Manfred did you read the discussion in the imbedded links? It seems that the explanation of the lower mortality is very well explained by stating that after the use of antibiotics but before the use of Neuprex the bacterial count was reduced to 1/8 of the maximum. There were three "articles" on line. The editorial, the main article and the commentary with footnotes. If you read the commentry with the footnotes, pardon me. Just trying to make sure. I value your opinion.